Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) Shareholder Notice: Lawsuit Against Acquisition Filed

A lawsuit was filed for investors in shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) in effort to halt the proposed takeover and NASDAQ:KYTH stockholders should contact the Shareholders Foundation.

Logo

San Diego, CA -- (SBWire) -- 07/14/2015 --An investor who currently holds shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), filed a lawsuit in effort to halt the proposed takeover of Kythera Biopharmaceuticals Inc by Allergan plc for a value of $75 per share is unfair to NASDAQ:KYTH stockholders.

Investors who purchased shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) and currently hold any of those NASDAQ:KYTH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:KYTH stockholders by agreeing to sell Kythera Biopharmaceuticals Inc. too cheaply via an unfair process to Allergan plc.

On June 17, 2015, Allergan plc (NYSE:AGN) and KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced that they have entered into an agreement under which Allergan has agreed to acquire Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion, subject to the fulfillment of certain customary conditions summarized below.

However, the plaintiff claims that the proposed consideration NASDAQ:KYTH shareholders will receive is grossly inadequate and undervalues Kythera Biopharmaceuticals Inc. Indeed, at least one analyst has set the high target price for NASDAQ: KYTH shares at $85.00 per share. . In addition, the plaintiff claims that the process is also unfair to NASDAQ:KYTH stockholders.

Shares of Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) closed on July 10, 2015, at $74.70 per share.

Those who are current investors in Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation, Inc.
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/609856